Released April 19, 2021 | KOFU, JAPAN
en
Researched by Industrial Info Resources (Sugar Land, Texas)--South Korea's largest pharmaceutical companies are focusing on producing biosimilar products. Samsung Biologics, Celltrion and Prestige Biologics are expanding their production facilities with $1.66 billion worth of projects, and other mid-sized companies are expected to focus on developing and producing biosimilars with an eye on both domestic and export markets.
According to Pfizer, a biosimilar product is a biologic product that is approved when it is proven to be highly similar to an already-approved biologic product, known as a reference product, and has no clinically meaningful differences in terms of safety and effectiveness from the reference product. Only minor differences in clinically inactive components are allowed in biosimilar products.
Click here for a list of projects, and see map below.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn. For more information on our coverage, send inquiries to info@industrialinfo.com or visit us online at http://www.industrialinfo.com.
According to Pfizer, a biosimilar product is a biologic product that is approved when it is proven to be highly similar to an already-approved biologic product, known as a reference product, and has no clinically meaningful differences in terms of safety and effectiveness from the reference product. Only minor differences in clinically inactive components are allowed in biosimilar products.
Click here for a list of projects, and see map below.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn. For more information on our coverage, send inquiries to info@industrialinfo.com or visit us online at http://www.industrialinfo.com.
